COSCIENS Biopharma Inc (CSCI)

[skitahoe]

I hope the FDA discussions involved the G-d's that head the department which must approve the drug. If it's just with the staff, what they've agreed to may not be sufficient when it goes before the boss.

That said, this is a positive, but clearly it will put approval of the drug well after AEZS-108 if trial results prove worthy. At this point that drug will drive the stock price, and our expectations.

In that they're being completely quiet about the Cancer Cachexia trial I've got to believe they're just letting it die the way big Pharma approaches early Phase Trials that fail to make the grade.

For now, I just hope they maintain the share price through the intended reverse split. While I hate these thing, occasionally they work, and this one will, if AEZS-108 works, if it doesn't, don't hold your breath for completion of new AEZS-130 Trials.

Gary